Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1991;11:64-70

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dobiasova, M.
Right arrow Articles by Frohlich, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dobiasova, M.
Right arrow Articles by Frohlich, J. J.

Arteriosclerosis and Thrombosis, Vol 11, 64-70, Copyright © 1991 by American Heart Association


ARTICLES

Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease

M Dobiasova, J Stribrna, DL Sparks, PH Pritchard and JJ Frohlich
Institute of Nuclear Biology and Radiochemistry, Czechoslovak Academy of Sciences, Prague.

The fractional rate of cholesterol esterification in very low density lipoprotein- and low density lipoprotein-depleted plasma (FERHDL) was studied in normolipidemic subjects and in individuals with hyperlipidemia and proven coronary artery disease (CAD). The FERHDL was significantly higher than the FER in whole plasma and was significantly higher in normal men than in normal women. In addition, men and women with primary hyperlipidemia had significantly higher FERHDL values relative to their sex-matched controls. The most significant increases in FERHDL values, however, were observed in individuals with CAD. In all patient groups, FERHDL was positively correlated with plasma triglyceride concentration. In addition, FERHDL was negatively related to plasma high density lipoprotein (HDL) cholesterol concentration in all groups except in men with CAD and in normolipidemic women. The gradient gel electrophoretic pattern of HDL from individuals with either low or high FERHDL values indicated an inverse relation between this activity and the relative amount of HDL2b particles. FERHDL likely reflects the metabolic properties of the heterogeneous population of HDL particles in the plasma and may be a function of the relative content of larger and smaller HDL particles. It appears to be a sensitive and reliable functional measure of the particle size distribution in the HDL pool and one of potential clinical value in the assessment of risk for CAD.


This article has been cited by other articles:


Home page
Clin. Chem.Home page
M. H. Tan, D. Johns, and N. B. Glazer
Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes
Clin. Chem., July 1, 2004; 50(7): 1184 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Frohlich and M. Dobiasova
Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography
Clin. Chem., November 1, 2003; 49(11): 1873 - 1880.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. D. Santos, W. Hueb, A. A. Oliveira, J. A. F. Ramires, and R. C. Maranhao
Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease
J. Lipid Res., March 1, 2003; 44(3): 464 - 469.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. W. Skeggs and R. E. Morton
LDL and HDL enriched in triglyceride promote abnormal cholesterol transport
J. Lipid Res., August 1, 2002; 43(8): 1264 - 1274.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. H. MOGHADASIAN, B. M. McMANUS, L. B. NGUYEN, S. SHEFER, M. NADJI, D. V. GODIN, T. J. GREEN, J. HILL, Y. YANG, C. H. SCUDAMORE, et al.
Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans
FASEB J, December 1, 2001; 15(14): 2623 - 2630.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. G. Brown, X.-Q. Zhao, A. Chait, L. D. Fisher, M. C. Cheung, J. S. Morse, A. A. Dowdy, E. K. Marino, E. L. Bolson, P. Alaupovic, et al.
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
N. Engl. J. Med., November 29, 2001; 345(22): 1583 - 1592.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. H. McGladdery and J. J. Frohlich
Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy
J. Lipid Res., November 1, 2001; 42(11): 1905 - 1912.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. J. Stamler, D. Breznan, T. A-M. Neville, F. J. Viau, E. Camlioglu, and D. L. Sparks
Phosphatidylinositol promotes cholesterol transport in vivo
J. Lipid Res., August 1, 2000; 41(8): 1214 - 1221.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
M. Dobiásová, L. Adler, T. Ohta, and J. Frohlich
Effect of labeling of plasma lipoproteins with [3H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma
J. Lipid Res., August 1, 2000; 41(8): 1356 - 1357.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. C. McManus, B. R. Scott, P. G. Frank, V. Franklin, J. R. Schultz, and Y. L. Marcel
Distinct Central Amphipathic alpha -Helices in Apolipoprotein A-I Contribute to the in Vivo Maturation of High Density Lipoprotein by Either Activating Lecithin-Cholesterol Acyltransferase or Binding Lipids
J. Biol. Chem., February 18, 2000; 275(7): 5043 - 5051.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Saku, B. Zhang, T. Ohta, and K. Arakawa
Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis
J. Am. Coll. Cardiol., February 1, 1999; 33(2): 436 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Argyropoulos, A. Jenkins, R. L. Klein, T. Lyons, B. Wagenhorst, J. St. Armand, S. M. Marcovina, J. J. Albers, P. H. Pritchard, and W. T. Garvey
Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure–function relationships and studies in a compound heterozygous proband
J. Lipid Res., September 1, 1998; 39(9): 1870 - 1876.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. H. Moghadasian, B. M. McManus, P. H. Pritchard, and J. J. Frohlich
"Tall Oil"–Derived Phytosterols Reduce Atherosclerosis in ApoE-Deficient Mice
Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 119 - 126.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Hasler-Rapacz, H. J. Kempen, H. M.G. Princen, B. J. Kudchodkar, A. Lacko, and J. Rapacz
Effects of Simvastatin on Plasma Lipids and Apolipoproteins in Familial Hypercholesterolemic Swine
Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 137 - 143.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. L. Sparks, W. S. Davidson, S. Lund-Katz, and M. C. Phillips
Effects of the Neutral Lipid Content of High Density Lipoprotein on Apolipoprotein A-I Structure and Particle Stability
J. Biol. Chem., November 10, 1995; 270(45): 26910 - 26917.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Murakami, S. Michelagnoli, R. Longhi, G. Gianfranceschi, F. Pazzucconi, L. Calabresi, C. R. Sirtori, and G. Franceschini
Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma
Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1819 - 1828.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Takata, K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa
A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease
Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1866 - 1874.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Ohta, K. Saku, K. Takata, R. Nakamura, Y. Ikeda, and I. Matsuda
Different Effects of Subclasses of HDL Containing ApoA-I but Not ApoA-II (LpA-I) on Cholesterol Esterification in Plasma and Net Cholesterol Efflux From Foam Cells
Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 956 - 962.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. L. Sparks, G. M. Anantharamaiah, J. P. Segrest, and M. C. Phillips
Effect of the Cholesterol Content of Reconstituted LpA-I on Lecithin:Cholesterol Acyltransferase Activity
J. Biol. Chem., March 10, 1995; 270(10): 5151 - 5157.
[Abstract] [Full Text] [PDF]